Collectively, these findings underscore the critical involvement of the cGAS/STING signaling pathway in the pathogenesis of sepsis-induced cardiomyopathy, highlighting its potential as a therapeutic target in septic cardiac dysfunction [26]. This evidence concerns the gene CGAS and cardiomyopathy.